e-Article
Delamanid for multidrug-resistant pulmonary tuberculosis
Document Type
Clinical report
Author
Gler, Maria Tarcela; Skripconoka, Vija; Sanchez-Garavito, Epifanio; Heping Xiao; Cabrera-Rivero, Jose L.; Vargas-Vasquez, Dante E.; Gao, Mengqiu; Awad, Mohamed; Park, Seung-Kyu; Tae Sun Shim; Gee Young Suh; Danilovits, Manfred; Ogata, Hideo; Kurve, Anu; Joon Chang; Suzuki, Katsuhiro; Tupasi, Thelma; Won-Jung Koh; Seaworth, Barbara; Geiter, Lawrence J.; Wells, Charles D.
Source
The New England Journal of Medicine. June 7, 2012, Vol. 366 Issue 23, p2151, 10 p.
Subject
Language
English
ISSN
0028-4793
Abstract
A study was conducted to evaluate the safety and efficacy of delamanid as a form of treatment for multidrug-resistant (MDR) pulmonary tuberculosis. Results indicated that delamanid was found to be significantly effective as a treatment option for MDR pulmonary tuberculosis.